HFSA-APAHFF 2022 | ||
0900 - 0905 | Welcome and Introduction Hong Fung, CEO, CUHK Medical Centre, Hong Kong SAR | |
SESSION I: HFSA-APAHFF 2022 Keynote Lecture Moderators: W. H. Wilson Tang (USA), Erik Fung (Hong Kong), Bryan P. Y. Yan (Hong Kong), G. M. Tan (Hong Kong) |
||
0905 - 0930 | HFpEF Therapy in 2022: What Drug and Why? James C. Fang (Salt Lake City, UT, USA) |
|
SESSION IIA: HFSA Lectures Moderators: Y. S. Archie Lo (Hong Kong), Godwin T. C. Leung (Hong Kong), Mário Évora (Macau) |
||
0930 - 0950 | Get-With-The-Guidelines & GDMT: Why It Matters Gregg C. Fonarow (Los Angeles, CA, USA) |
|
0950 - 1010 | Cardiovascular and Heart Failure Management of COVID-19: The New York Experience Nir Uriel (New York, NY, USA) |
|
1010 - 1030 | The Clinical Examination in Patients with Heart Failure: New Insights Mark H. Drazner (Dallas, TX, USA) |
|
SESSION IIB: HFSA Lectures Moderators: Zaheer Yousef (Cardiff, UK), Erik Fung (Hong Kong), Michael W. Fong (Los Angeles, USA) |
||
1030 - 1050 | Novel Medical Therapies for Heart Failure and Cardiomyopathies W. H. Wilson Tang (Cleveland, OH, USA) |
|
1050 - 1110 | The Future of Mechanical Circulatory Support Mandeep R. Mehra (Boston, MA, USA) |
|
1110 - 1130 | Pulmonary Decongestion in Heart Failure: Who Are the High-Risk Patients Lynne W. Stevenson (Nashville, TN, USA) |
|
SESSION IIC: HFSA Lectures Moderators: Eugene B. Wu (Hong Kong), Yu Ho Chan (Hong Kong), Wei-Ting Wang (Taipei) |
||
1130 - 1150 | Advances in Percutaneous VAD Technology Navin K. Kapur (Boston, MA, USA) |
|
1150 - 1210 | State-of-The-Art in Invasive Hemodynamics Nancy K. Sweitzer (Tucson, AZ, USA) |
|
1210 - 1230 | Bridging Patients Safely from VAD to Transplant Jennifer A. Cowger (Detroit, MI, USA) |
|
1230 - 1330 | Lunch Break | |
Distinguished Professorial Lecture Moderators: Roger S. Y. Foo (Singapore), Erik Fung (Hong Kong), W. H. Wilson Tang (Cleveland, OH, USA) |
||
1330 - 1350 | Mechanisms of Heart Failure in Hypoplastic Left Heart Syndrome Cecilia W. Lo (Pittsburgh, PA, USA) |
|
1350 - 1500 | European Heart Journal Special Session Moderator: Timothy C. Wong (Pittsburgh, PA, USA), Ganesan Karthikeyan (New Delhi, India), Chi-Ming Chow (Toronto, ONT, Canada) | 1350 - 1405 | Leadership in Academic Cardiology: How to publish in the European Heart Journal Filippo Crea (Editor-in-Chief, European Heart Journal; Rome, Italy) |
1405 - 1420 | Cardiac Magnetic Resonance Imaging in Heart Failure Chiara Bucciarelli-Ducci (Deputy Editor, European Heart Journal; London, UK) |
1420 - 1435 | Circulating Biomarkers for Heart Failure: quo vadis? Antoni Bayés-Genís (Barcelona, Spain) |
1435 - 1450 | Multimodality Cardiovascular Imaging in the Investigation of Decompensated Heart Failure in Patients with Adult Congenital Heart Disease Kin-Shing Lun (Hong Kong) |
1450 - 1500 | Roundtable Discussion |
1500 - 1540 | SESSION III: Cardiac Transplantation in the Asia Pacific Region Moderators: Glenn Rose Advincula (Philippines), Steven Tsui (Cambridge, UK) |
SESSION IV: Cardiac Electrophysiology Moderators: Gary C. P. Chan (Hong Kong), Cheuk Man Yu (Hong Kong) |
1500 - 1510 | Machine Perfusion of Donor Hearts Peter S. Macdonald (Sydney, Australia) |
Atrial Fibrillation in Heart Failure: A case for prevention Ching Hui Sia (Singapore) |
1510 - 1520 | Review and Updates on Heart Transplant in South Korea: Impact of Administrative Systems Change on the Frontline Yang Hyun Cho (S. Korea) |
AF Ablation for Patients with Heart Failure Yan Wang (Wuhan, China) |
1520 - 1530 | Successes and Challenges of Heart Transplantation in India Over the Past Two Decades Sandeep Seth (New Delhi, India) |
Cardiac Contractility Modulation for Advanced Heart Failure Jo Jo Hai (Hong Kong) |
1530 - 1540 | Roundtable Discussion | Roundtable Discussion |
1540 - 1620 | SESSION V: Mechanical Circulatory Support Moderators: Goro Matsumiya (Chiba, Japan), |
SESSION VI: Pulmonary Hypertension and The Right Heart Moderators: Edmund M. T. Lau (Sydney, Australia), Kevin K. H. Kam (Hong Kong), Toi-meng Mok (Macau), Yuichi Tamura (Tokyo, Japan) |
1540 - 1550 | LVAD implantations in Hong Kong Cally K. L. Ho (Hong Kong) |
The Hemodynamic Characteristics Of Severe Chronic Lung Disease Referred For Lung Transplantation In Hong Kong Michael K. L. Wong (Hong Kong) |
1550 - 1600 | Destination Therapy (Durable) LVAD Program at Chiba University Hospital and in Japan Hiroki Kohno (Chiba, Japan) |
Recent controversies in initiation of drug therapy for pulmonary arterial hypertension Edmund M. T. Lau (Sydney, Australia) |
1600 - 1610 | Impact of Change in UNOS Priority Listing on VAD Implantation at Keck Hospital of USC: A Perspective from Los Angeles, California Michael W. Fong (Los Angeles, USA) |
Epidemiology and Disease Management of Pulmonary Hypertension During The Last Two Decades in Japan Yuichi Tamura (Tokyo, Japan) |
1610 - 1620 | Roundtable Discussion | Roundtable Discussion |
1620 - 1640 | Tea Break | |
1640 - 1720 | SESSION VII: Diabetic Cardiomyopathy Moderators: Mónica Pon (Macau), Juliana C. N. Chan (Hong Kong), Alice P. S. Kong (Hong Kong) |
SESSION VIII: Cardiac Rehabilitation Moderators: Lucky R. Cuenza (Philippines), Ngai Yin Chan (Hong Kong) |
1640 - 1650 | miR-320 and Diabetic Cardiomyopathy Dao Wen Wang (Wuhan, China) |
Cardiac Rehab Program at National University Heart Centre, Singapore Tee Joo Yeo (Singapore) |
1650 - 1700 | Human Induced Pluripotent Stem Cell Modelling for Diabetic Cardiomyopathy and its Susceptibility to SARS-CoV2 myocardial damage David C. W. Siu (Hong Kong) |
Updates on the Progress and Development of Cardiac Rehabilitation in Asia Ngai Yin Chan (Hong Kong) |
1700 - 1710 | Optimal Management of Glucose and Extraglycemic Risks in Patients with Heart Failure and Diabetes Andrea O. Y. Luk (Hong Kong) |
Cardiac Rehab Program at CUHK Medical Centre Eva Y. W. Chun (Hong Kong) |
1710 - 1720 | Roundtable Discussion | Roundtable Discussion |
1720 - 1800 | SESSION IX: Cardiorenal Interactions Moderators: Narittaya Varothai (Bangkok, Thailand), Ling Ling Ip (Hong Kong), Ka Lung Chui (Hong Kong) |
SESSION X: Palliative Care Moderators: Huei Yaw Wu (Singapore), Raymond S. K. Lo (Hong Kong), Tung Wai AuYeung (Hong Kong) |
1720 - 1730 | The Cardiorenal Axis, A Love-hate Relationship: Can Manipulating The Kidney Affect The Heart? Marjorie W. Y. Foo (Singapore) |
Interethnic Differences in Advance Care Planning for End-Stage Heart Failure: Practice Tips from Singapore Shirlyn H. S. Neo (Singapore) |
1730 - 1740 | Diabetic Cardiomyopathy and Nephropathy: Lessons from The Hong Kong Diabetes Register Ronald C. W. Ma (Hong Kong) |
Managing Frailty in End-Stage Heart Failure Sunita Puri (Los Angeles, CA, USA) |
1740 - 1750 | Intensive Volume Removal in Patients with Advanced Heart Failure and Chronic Kidney Disease: Pitfalls and Pearls Narittaya Varothai (Bangkok, Thailand) |
Inotropic Support for End-Stage Heart Failure in the Ambulatory Setting Erik Fung (Hong Kong) |
1750 - 1800 | Roundtable Discussion | Roundtable Discussion |